How Rifampin Affects Famciclovir's Potency
Rifampin reduces famciclovir's potency by strongly inducing CYP3A4 and other hepatic enzymes, accelerating famciclovir's metabolism and lowering its active metabolite penciclovir's plasma levels by about 70%.[1][2]
Famciclovir itself is a prodrug converted to penciclovir, the active antiviral that inhibits herpesvirus DNA polymerase. Rifampin speeds up penciclovir's clearance, dropping its AUC and peak concentrations, which cuts antiviral effectiveness against viruses like herpes zoster or simplex.[1][3]
Why Does Rifampin Cause This Interaction?
Rifampin is a potent inducer of cytochrome P450 enzymes (CYP3A4, CYP2C9, CYP1A2) and P-glycoprotein via activation of the pregnane X receptor (PXR). Famciclovir and penciclovir are substrates for these pathways, so induction ramps up their breakdown and efflux from cells, reducing systemic exposure.[2][4]
Clinical Evidence from Studies
In a crossover study with healthy volunteers, rifampin 600 mg daily for 6 days cut penciclovir's AUC by 69%, Cmax by 54%, and half-life from 2.3 to 1.3 hours after a single 500 mg famciclovir dose. No dose adjustment was tested for efficacy restoration.[1]
Case reports and PK models confirm higher failure rates in coinfected patients, like those with TB and herpes reactivation.[3]
Dosage Adjustments and Management
Guidelines recommend avoiding concurrent use or increasing famciclovir dose 2-fold (e.g., from 500 mg to 1 g three times daily for zoster). Monitor viral response clinically; switch to non-interacting antivirals like IV acyclovir if severe.[2][5]
Compared to Other Enzyme Inducers
| Inducer | Effect on Penciclovir AUC | Strength |
|---------|---------------------------|----------|
| Rifampin | ↓70% | Strong |
| Rifabutin | ↓50% | Moderate |
| Phenytoin | ↓30-40% | Moderate |
| Carbamazepine | ↓40% | Moderate[4] |
Rifampin has the strongest impact among rifamycins.
Patient Risks and Monitoring
Lower potency raises breakthrough infection risk, especially in immunocompromised patients. Watch for delayed viral clearance or resistance. Rifampin also induces glucuronidation of penciclovir, compounding the drop.[3]
Alternatives When Rifampin Is Needed
Use valacyclovir (less CYP-dependent) or acyclovir, though both face milder induction (AUC ↓20-30%). Foscarnet or cidofovir for resistant cases, bypassing penciclovir pathway.[5]
Sources
[1]: Pharmacokinetic interaction study (PubMed)
[2]: Lexicomp Drug Interaction Database
[3]: Clinical Pharmacology Review (FDA Label)
[4]: Drug Interactions Table (UpToDate)
[5]: HIV Guidelines (NIH)